Open AccessAnosmia with or without Ageusia as a Presenting Symptom in COVID-19 Positive Patients: A Single Center Study at Dhaka in Bangladesh
Author(s) -
Arifa Akram,
M. Z. I. Khan,
Md. Ashiqur Rahman,
Md. Raihanul Islam,
Md Mahbub Ali,
Tazul Islam,
Lubana Akram,
Md. Abdullah Yusuf,
Md Tanjimul Islam,
Md Alimur Reza
Publication year - 2022
Publication title -
bangladesh journal of infectious diseases
Language(s) - English
Resource type - Journals
eISSN - 2411-670X
pISSN - 2411-4820
DOI - 10.3329/bjid.v8i1.57953
Subject(s) - anosmia , medicine , covid-19 , taste , incidence (geometry) , single center , dysgeusia , disease , infectious disease (medical specialty) , pathology , adverse effect , food science , chemistry , physics , outbreak , optics
Background: The loss of smell and taste in COVID-19 patients is now acknowledged as one of the disease’s primary symptoms.
Objective: The aim of this study was to investigate the incidence of loss of smell and taste in outpatients and hospitalized patients with SARS-CoV-2 infection that RT-PCR had confirmed.
Methodology: This cross-sectional study was conducted in the in the Novus Molecular Lab, Dhaka between 5 June 2021 and 17 July 2021]. COVID-19 patients were included in this study who become RT-PCR positive in nasopharyngeal and oropharyngeal swabs in a single center. All of them were interviewed by a structured questionnaire over the phone.
Results: Among 200 COVID-19-positive patients smell and taste dysfunction appeared among 75(37.5%) patients. Only smell dysfunction occurred in 57.0% of patients, and taste dysfunction appears in 34.0% patients, and both symptoms were present among 9.0% of patients with or without other symptoms of COVID-19. The smell and taste recovery time was distributed as 63.0% recovered within less than a week, 20.0% within 2 weeks, and 17.0% in 2 weeks.
Conclusion: In conclusion significant number of COVID-19 patients are presented with loss of smell and taste.
Bangladesh Journal of Infectious Diseases June 2021;8(1):32-35